Skip to main content
    O

    Orthopediatrics Corp (KIDS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $31.50
    -0.85 (-2.63%)

    Market Cap: $844.67M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Orthopediatrics Corp (KIDS) Financials: Revenue, Profit and Cash Flow

    Updated Oct 27, 2026. Financial statements from company filings, amounts in US dollars.

    Orthopediatrics reported revenue of $236.35M for the fiscal year ended Dec 31, 2025, up 15.4% from the year before. That year, net income was -$39.65M with a net margin of -16.8%, operating cash flow was -$4.85M and free cash flow was -$15.96M. The quarter ended Sep 30, 2026 had revenue of $72.66M and net income of -$5.93M.

    Revenue and Margins

    The operating margin was -16.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $37.30M, a compound annual rate of 22.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$236.35M+15.4%73.1%-16.6%-16.8%
    Dec 2024$204.73M+37.6%72.6%-17.1%-18.5%
    Dec 2023$148.73M+21.6%74.8%-18.0%-14.1%
    Dec 2022$122.29M+24.7%74.1%-20.8%1.0%
    Dec 2021$98.05M+37.9%74.9%-18.4%-16.6%
    Dec 2020$71.08M-2.0%77.4%-37.6%-46.3%
    Dec 2019$72.55M+26.0%75.3%-12.5%-18.9%
    Dec 2018$57.56M+26.2%74.2%-16.6%-20.9%
    Dec 2017$45.62M+22.3%75.5%-14.2%-19.6%
    Dec 2016$37.30MN/A70.7%-16.4%-17.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$236.35M$204.73M$148.73M$122.29M$98.05M$71.08M$72.55M$57.56M$45.62M$37.30M
    Cost of revenue$63.69M$56.13M$37.48M$31.63M$24.65M$16.05M$17.93M$14.88M$11.17M$10.93M
    Gross profit$172.66M$148.60M$111.25M$90.66M$73.40M$55.03M$54.62M$42.68M$34.45M$26.37M
    Research and development$9.10M$11.03M$10.89M$8.45M$5.54M$5.27M$5.75M$4.73M$3.42M$2.22M
    Operating income-$39.24M-$35.01M-$26.75M-$25.40M-$18.02M-$26.75M-$9.08M-$9.55M-$6.47M-$6.13M
    Net income-$39.65M-$37.82M-$20.97M$1.26M-$16.26M-$32.94M-$13.73M-$12.03M-$8.93M-$6.57M
    EBITDA-$12.07M-$17.00M-$4.13M$11.83M-$4.46M-$18.73M-$4.48M-$6.88M-$4.04M-$3.19M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$72.66M$70.51M$59.36M$61.60M$61.25M$61.08M$52.41M$52.67M$54.57M$52.80M$44.69M$37.61M
    Gross profit$53.98M$52.37M$43.39M$45.11M$45.27M$44.02M$38.26M$35.56M$40.06M$40.80M$32.17M$26.71M
    Operating income-$4.22M-$4.07M-$8.34M-$8.17M-$9.43M-$10.66M-$10.98M-$14.05M-$5.57M-$5.67M-$9.72M-$8.07M
    Net income-$5.93M-$7.16M-$10.69M-$10.10M-$11.77M-$7.11M-$10.66M-$16.07M-$7.92M-$6.03M-$7.80M-$6.69M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $99.99M exceeded cash and equivalents by $80.43M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$508.63M$473.21M$438.75M$427.73M$304.27M$320.41M$182.15M$112.11M$82.30M$30.68M
    Current assets$256.42M$237.17M$226.50M$226.72M$133.65M$158.43M$128.06M$97.16M$69.56M$20.83M
    Cash and equivalents$19.56M$43.82M$31.05M$8.99M$9.01M$28.76M$70.78M$60.69M$42.58M$1.61M
    Total liabilities$162.03M$118.64M$61.72M$49.08M$78.91M$85.64M$39.79M$30.37M$34.81M$24.68M
    Short-term debt$170.00K$160.00K$152.00K$144.00K$137.00K$131.00K$124.00K$118.00K$113.00K$107.00K
    Long-term debt$99.82M$72.96M$9.91M$763.00K$907.00K$1.04M$26.07M$21.16M$25.34M$17.43M
    Shareholder equity$346.60M$354.57M$377.02M$378.65M$225.37M$234.77M$142.36M$81.73M$47.49M-$65.31M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$509.09M$511.39M$502.19M$508.63M$493.49M$503.61M$470.25M$473.21M$489.29M$430.76M$437.19M$438.75M
    Total liabilities$169.74M$167.77M$163.48M$162.03M$144.18M$148.09M$123.10M$118.64M$118.38M$59.47M$66.60M$61.72M
    Cash and equivalents$17.14M$17.00M$12.19M$19.56M$16.83M$44.55M$33.44M$43.82M$51.05M$28.93M$21.60M$31.05M
    Shareholder equity$339.35M$343.61M$338.71M$346.60M$349.31M$355.51M$347.15M$354.57M$370.92M$371.29M$370.58M$377.02M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$4.85M-$27.05M-$27.05M-$21.77M-$13.06M-$18.53M-$17.77M-$15.58M-$7.22M-$1.12M
    Capital expenditures$11.11M$14.26M$17.42M$10.03M$8.10M$10.50M$11.82M$5.25M$5.21M$4.35M
    Free cash flow-$15.96M-$41.31M-$44.47M-$31.80M-$21.17M-$29.03M-$29.59M-$20.84M-$12.42M-$5.47M
    Dividends paidN/AN/AN/AN/AN/AN/A$0$0$5.96M$0
    Share repurchasesN/AN/AN/AN/AN/AN/AN/AN/AN/A$794.00K
    Investing cash flow-$43.63M-$13.16M$41.68M-$113.37M-$7.41M-$69.69M-$61.92M-$5.96M-$6.54M-$4.75M
    Financing cash flow$23.98M$53.13M$7.30M$135.97M$6.00K$46.73M$91.02M$39.66M$54.73M$3.60M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$4.51M$928.00K-$3.29M$10.35M-$581.00K-$10.46M-$4.16M-$3.99M-$10.28M-$6.09M-$6.69M-$7.54M
    Capital expenditures$2.91M$4.04M$1.76M$599.00K$2.84M$3.44M$4.23M$262.00K$1.38M$6.68M$6.46M$3.84M
    Free cash flow$1.59M-$3.12M-$5.05M$9.75M-$3.42M-$13.91M-$8.38M-$4.25M-$11.66M-$12.78M-$13.15M-$11.38M
    Last 12 quarters

    Frequently Asked Questions About KIDS

    What is Orthopediatrics' annual revenue?

    Orthopediatrics reported revenue of $236.35M for the fiscal year ended Dec 31, 2025.

    How fast is Orthopediatrics' revenue growing?

    Revenue was up 15.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 24.6%.

    Is Orthopediatrics profitable?

    No. Orthopediatrics reported net income of -$39.65M for the fiscal year ended Dec 31, 2025, with a net margin of -16.8%.

    How much free cash flow does KIDS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$4.85M minus capital expenditures of $11.11M produced free cash flow of -$15.96M.

    How much debt does Orthopediatrics have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $99.82M, short-term debt of $170.00K and cash and equivalents of $19.56M.